At-home Self-testing Kits Market, 2022-2035 - Distribution by Type of Test Format, Type of Biofluid Analyzed Therapeutic Area and Key Geographical Regions (North America, Europe, Asia-Pacific, Africa and South America )

Since the approval of the first over-the-counter test kits in the early 1976, there has been a substantial increase in the development initiatives focused on such products. In this context, it is worth highlighting that over 20 million at-home pregnancy test kits are being annually sold in the US. Companies have also developed at-home diagnostic kits for the detection and diagnosis of various diseases, such as human immunodeficiency virus (HIV) infection, diabetes, Hepatitis C, colon cancer and COVID-19. Specifically, post the onset of COVID-19, there has been an upsurge in the demand for self-testing kits. In fact, in 2021, more than 100 at-home self-testing kits were approved by the USFDA for the diagnosis of COVID-19. The popularity of these kits can be attributed to the fact that they are more reliable, efficient, high yielding, as well as compatible with a broad range of input samples, including blood, cells, tissues, plasma, saliva and microbes.

Given the extensive utilization of at-home testing kits in the diagnosis of a myriad of disease indications, there has been a significant rise in investments in this domain. Over USD 2.2 billion has been invested in this domain by various government institutions in the US, over the last five years. Further, the current market landscape is consolidated and primarily dominated by the kits being developed to detect pregnancies, monitoring glucose and ovulation patterns. We believe that, with an increase in the number of point-of-care test kits being developed across various therapeutic areas, such as infectious diseases and celiac diseases, and their subsequent commercialization, the opportunities for self-testing kit developers is likely to increase in the foreseen future. At present, efforts are also ongoing to connect at-home diagnostic tests with telemedicine; this is expected to enable a rapid turnaround time. The ongoing innovations in this market are anticipated to bring a positive revolution in the healthcare domain. Given the continuous efforts being undertaken by industry players, the at-home self-testing kits market is poised to witness healthy growth over the next decade.

SCOPE OF THE REPORT

The "At-home Self-testing Kits Market, Distribution by Type of Test Format (Strip, Stick, Cassette, and Others), Type of Biofluid Analyzed (Urine, Blood, and Stool), Therapeutic Area (Fertility and Reproductive Health, Metabolic Disorders, Infectious Diseases and Oncological Disorders) and Key Geographical Regions (North America (US, Canada and Rest of North America), Europe (UK, Germany, France, Italy, Spain and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Indonesia and Rest of Asia-Pacific), Africa (Nigeria, Ethiopia, Egypt and Rest of Africa) and South America (Argentina, Brazil and Rest of South America)): Industry Trends and Global Forecasts, 2022-2035" report features an extensive study of the current market landscape and future potential associated with the at-home self-testing kits market. The study also includes an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field. Amongst other elements, the report features:

A brief overview of at-home self-testing kits, highlighting the key steps involved while performing at-home self-tests. Further, it highlights the types of at-home tests available, and the types of assays used. The chapter also elaborates on the advantages offered by at-home self-testing kits along with the associated challenges. In addition, the chapter provides information on different regulatory authorities across key geographies which are involved in regulating the approval, safety, and sales of at-home self-testing kits and its future perspectives.

A detailed overview of the current market landscape of companies engaged in the development of at-home self-testing kits, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of testing procedure (manual and automatic), type of test format (strip, stick, cassette, and others), purpose of testing (cancer screening, pregnancy detection, diabetes monitoring, ketone monitoring, HIV diagnosis, ovulation monitoring, substance abuse monitoring and, others), target therapeutic area (fertility and reproductive health, metabolic disorders, oncological disorders, infectious diseases, hematological disorders, and others), wearability (wearable and non-wearable), analyte procurement method (invasive and non-invasive), biofluid analyzed (blood, saliva, urine, stool, and others), processing time (maximum processing time), kit components (diagnostic component, collection component, lancets, reagents, and other components), regulatory approvals / certifications (CE, ISO, FDA, IVD, and others), kit reusability, availability of data management tools, target analyte detected (hemoglobin, glucose, FSH, LH, hCG, cholesterol, and others), and follow-up consultation requirement.

A detailed analysis of academic grants that have been awarded to various research institutes for conducting research focused on at-home self-testing kits, during the period, pre-2019-2022, based on several parameters, such as year of grant award, amount awarded, support period, type of funding institute center, grant application, purpose of grant award, grant activity code, NIH spending category, study section involved, popular NIH departments, recipient organization, regional distribution of recipient organization. Further, the chapter also highlights the popular recipient organizations, (in terms of number of grants and amount awarded) and prominent program officers (in terms of number of grants).

A detailed competitiveness analysis of at-home self-testing kit manufacturers based on overall experience of the company (in terms of number of years since its establishment), product portfolio strength (in terms of number of at-home self-testing kits offered) and portfolio diversity (in terms of type of test format, type of biofluid analyzed, number of regulatory approvals, kit reusability, accessibility, and number of target analytes).

Elaborate profiles of prominent players engaged in offering at-home self-testing kits. Each profile includes a brief overview of the company, along with details related to its financial information (if available), information on product portfolio, recent developments and an informed future outlook.

A Bowman's strategy clock framework to understand the pricing strategy of the at-home self-testing kits offered by a company, along with its competitive position in the market. In addition, it presents the equation devised to calculate the likely price of the at-home self-testing kits based upon its characteristics.

An estimate of company's intrinsic value by utilizing comparable company analysis of publicly listed companies based on their current share price, equity value, enterprise value, EBITDA, net income, and revenue.

An informed estimate of the annual demand (in terms of number of kits) for at-home self-testing kits, across various therapeutic areas, such as fertility and reproductive health, metabolic disorders, infectious diseases, and oncological disorders.

A detailed analysis based on a proprietary 2×2 representation, highlighting the current market scenario (in terms of existing competition and growth opportunities) across emerging and established market segments.

An overview of at-home self-testing kits, highlighting the key steps involved while performing at-home self-tests, types of home-tests and types of assays used. The chapter also elaborates on the advantages offered by at-home self-testing kits along with the associated challenges. In addition, the chapter provides information on different regulatory authorities across key geographies which are involved in regulating the approval, safety, and sales of at-home self-testing kits

One of the key objectives of the report was to estimate the current opportunity and future size of at-home self-testing kits market. We have provided informed estimates on the likely evolution of the market in the short to mid-term and long term, over the period 2022-2035. Our year-wise projections of the current and future opportunity have further been segmented on the basis of [A] therapeutic area (fertility and reproductive health, metabolic disorders, infectious diseases, and oncological disorders), [B] type of biofluid analyzed (blood, urine, and stool), [C] type of test format (cassette, strip, stick and others), [D] key geographical regions (North America, Europe, Asia-Pacific, Africa, and South America). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry's growth.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

RESEARCH METHODOLOGY

The data presented in this report has been gathered via secondary and primary research. For all our projects, we have conducted interviews with various experts in this domain (academia, industry, medical practice and other associations) in order to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions. Wherever possible, the available data has been validated from multiple sources of information.

The secondary sources of information include:

Annual reports
Investor presentations
SEC filings
Industry databases
News releases from company websites
Government policy documents
Industry analysts' views

While the focus has been on forecasting the market till 2035, the report also provides our independent view on various trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market, gathered from various secondary and primary sources of information.

KEY QUESTIONS ANSWERED

Who are the leading players engaged in the manufacturing of at-home self-testing kits?

What is the most common diagnostic assay offered by at-home self-testing kit manufacturers?

What are the key regulatory frameworks for at-home self-testing kits across different geographical regions?

Which companies / institutes have received grants for the research and development of at-home self-testing kits?

What are the key factors influencing the price of at-home self-testing kits?

What is the likely valuation / net worth of companies engaged in this domain?

What is the current, global demand for at-home self-test kits?

How is the current and future market opportunity likely to be distributed across key market segments?

What is the current market scenario (in terms of existing competition and growth opportunities) across emerging and established market segments?

CHAPTER OUTLINES

Chapter 2 is an executive summary of the key insights captured during our research. It offers a high-level view on the current state of at-home self-testing kits market and its likely evolution in the mid to long-term.

Chapter 3 features a brief overview of at-home self-testing kits, highlighting the key steps involved while performing at-home self-tests. Further, it highlights the types of at-home tests available, and the types of assays used. The chapter also elaborates on the advantages offered by at-home self-testing kits along with the associated challenges. In addition, the chapter provides information on different regulatory authorities across key geographies which are involved in regulating the approval, safety, and sales of at-home self-testing kits and its future perspectives.

Chapter 4 provides a detailed overview of the current market landscape of at-home self-testing kit developers, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of testing procedure (manual and automatic), type of test format (strip, stick, cassette, and others), purpose of testing (cancer screening, pregnancy detection, diabetes monitoring, ketone monitoring, HIV diagnosis, ovulation monitoring, substance abuse monitoring and, others), target therapeutic area (fertility and reproductive health, metabolic disorders, oncological disorders, infectious diseases, hematological disorders, and others), wearability (wearable and non-wearable), analyte procurement method (invasive and non-invasive), biofluid analyzed (blood, saliva, urine, stool, and others), processing time (maximum processing time), kit components (diagnostic component, collection component, lancets, reagents, and other components), regulatory approvals / certifications (CE, ISO, FDA, IVD, and others), kit reusability, availability of data management tools, target analyte detected (hemoglobin, glucose, FSH, LH, hCG, cholesterol, and others), and follow-up consultation requirement.

Chapter 5 presents an analysis on academic grants that have been awarded to various research institutes for projects focused on at-home self-testing kits, during the period, pre-2019-2022, based on several relevant parameters, such as year of grant award, amount awarded, support period, grant application, purpose of grant award, grant activity code, NIH spending category, study section involved, popular NIH departments, recipient organization, regional distribution of recipient organization. Further, the chapter also highlights the popular recipient organizations, (in terms of number of grants and amount awarded) and prominent program officers (in terms of number of grants).

Chapter 6 provides an insightful competitiveness analysis of at-home self-testing kit manufacturers based on various relevant parameters, such as overall experience of the company (in terms of number of years since it was established), product portfolio strength (in terms of number of at-home self-testing kits offered) and portfolio diversity (in terms of type of test format, types of biofluid analyzed, number of regulatory approvals, kit reusability, availability of data management tools, and number of target analytes).

Chapter 7 provides elaborate profiles of prominent players engaged in this domain. Each profile includes a brief overview of the company, details related to its financial information (if available), information on product portfolio, recent developments, and an informed future outlook.

Chapter 8 presents a Bowman's strategy clock framework to understand the pricing strategy of the at-home self-test kits offered by a company, along with its competitive position. In addition, it presents the equation devised to calculate the likely price of the at-home self-test kits based upon different therapeutics areas, such as, fertility and reproductive health, metabolic disorders, infectious diseases, and oncological disorders.

Chapter 9 provides an estimate of company's intrinsic value by utilizing comparable company analysis of publicly listed companies based on their current share price, equity value, enterprise value, EBITDA, net income, and revenue.

Chapter 10 provides an informed estimate of the annual demand for at-home self-testing kits, across various therapeutic areas such as, fertility and reproductive health, metabolic disorders, infectious diseases, and oncological disorders.

Chapter 11 presents an insightful market forecast analysis, highlighting the future potential of at-home self-testing kits market till 2035. We have segmented on the basis of therapeutic area (fertility and reproductive health, metabolic disorders, infectious diseases, and oncological disorders), type of biofluid analyzed (blood, urine, stool, and others), type of test format (cassette, strip, stick, and others), key geographical regions (North America, Europe, Asia-Pacific, Africa, and South America).

Chapter 12 presents a detailed analysis based on a proprietary 2×2 representation, highlighting the current market scenario (in terms of existing competition and growth opportunities) across emerging and established market segments.

Chapter 13 is a summary of the overall report, presenting the insights on the contemporary market trends and the likely evolution of the at-home self-testing kits market.

Chapter 14 contains the transcripts of interviews conducted with representatives from renowned organizations that are engaged in offering at-home self-testing kits. The chapter provides details of interviews held with (in alphabetical order) Ben Shen (Vice President - Sales and Marketing, Apex Biotechnology), Joy Chatterjee (Associate Vice President - Sales and Marketing, Mankind Pharma).

Chapter 15 is an appendix, which provides tabulated data and numbers for all the figures in the report.

Chapter 16 is an appendix, which provides the list of companies and organizations mentioned in the report.

Product Code: RA100385

1. PREFACE

1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

2.1. Chapter Overview

3. INTRODUCTION

3.1. Chapter Overview
3.2. Introduction to At-Home Self-Testing
3.3. Types of At-home Tests
3.4. Types of At-home Test Assays
3.5. Advantages and Disadvantages Associated with At-home Self-testing Kits
3.6. Regulations Established for At-home Self-testing Kits
3.7. Future Perspectives

4. MARKET OVERVIEW

4.1. Chapter Overview
4.2. At-home Self-testing Kits: List of Developers
- 4.2.1. Analysis by Year of Establishment
- 4.2.2. Analysis by Company Size
- 4.2.3. Analysis by Location of Headquarters
- 4.2.4. Analysis by Company Size and Location of Headquarters
- 4.2.5. Analysis by Year of Establishment, Company Size and Location of Headquarters
4.3. At-home Self-testing Kits: Overall Market Landscape
- 4.3.1. Analysis by Type of Testing Procedure
- 4.3.2. Analysis by Type of Test Format
- 4.3.3. Analysis by Purpose of Testing
- 4.3.4. Analysis by Target Therapeutic Area
- 4.3.5. Analysis by Kit Components
- 4.3.6. Analysis by Kit Wearability
- 4.3.7. Analysis by Target Analyte Detected
- 4.3.8. Analysis by Type of Analyte Procurement Method
- 4.3.9. Analysis by Type of Biofluid Analyzed
- 4.3.10. Analysis by Processing Time
- 4.3.11. Analysis by Number of Regulatory Approvals
- 4.3.12. Analysis by Kit Reusability
- 4.3.13. Analysis by Availability of Data Management Tools
- 4.3.14. Analysis by Follow-up Consultation Requirement

5. GRANTS ANALYSIS

5.1. Chapter Overview
5.2. Scope and Methodology
5.3. At-home Self-testing Kits: Grant Analysis
- 5.3.1. Analysis by Year of Grant Award
- 5.3.2. Analysis by Amount Awarded
- 5.3.3. Analysis by Support Period
- 5.3.4. Analysis by Support Period and Funding Institute Center
- 5.3.5. Analysis by Type of Grant Application
- 5.3.6. Analysis by Purpose of Grant Award
- 5.3.7. Analysis by Activity Code
- 5.3.8. Analysis by NIH Spending Categories (Word Cloud Representation)
- 5.3.9. Analysis by Study Section Involved
- 5.3.10. Popular NIH Departments: Analysis by Number of Grants
- 5.3.11. Analysis by Type of Recipient Organization
- 5.3.12. Prominent Program Officers: Analysis by Number of Grants
- 5.3.13. Popular Recipient Organizations: Analysis by Number of Grants
- 5.3.14. Popular Recipient Organizations: Analysis by Amount Awarded
- 5.3.15. Analysis by Region of Recipient Organization

6. COMPANY COMPETITIVENESS ANALYSIS

6.1. Chapter Overview
6.2. Key Assumptions and Parameters
6.3. Methodology
6.4. At-home Self-testing Kit Developers: Company Competitiveness Analysis
- 6.4.1. At-home Self-testing Kits Developers Based in North America
- 6.4.2. At-home Self-testing Kits Developers Based in Europe
- 6.4.3. At-home Self-testing Kits Developers Based in Asia-Pacific
- 6.4.4. At-home Self-testing Kits Developers: Competitive Benchmarking

7. COMPANY PROFILES

7.1. Chapter Overview
7.2. ACON Laboratories
- 7.2.1. Product Portfolio
- 7.2.2. Recent Developments and Future Outlook
7.3. AdvaCare Pharma USA
- 7.3.1. Product Portfolio
- 7.3.2. Recent Developments and Future Outlook
7.4. Apex Biotechnology
- 7.4.1. Product Portfolio
- 7.4.2. Recent Developments and Future Outlook
7.5. i-SENS
- 7.5.1. Financial Information
- 7.5.2. Product Portfolio
- 7.5.3. Recent Developments and Future Outlook
7.6. Oak Tree Health
- 7.6.1. Product Portfolio
- 7.6.2. Recent Developments and Future Outlook
7.7. TaiDoc Technology
- 7.7.1. Product Portfolio
- 7.7.2. Recent Developments and Future Outlook
7.8. VivaCheck Laboratories
- 7.8.1. Product Portfolio
- 7.8.2. Recent Developments and Future Outlook

8. BOWMAN CLOCK PRICING STRATEGY

8.1. Chapter Overview
8.2. Bowman Strategy Clock
- 8.2.1. Two Dimensions of Bowman Strategy Clock
- 8.2.2. Eight Positions on Bowman Strategy Clock
8.3. Roots Analysis Framework
- 8.3.1. Methodology
- 8.3.2. Theoretical Framework and Price Evaluation Hypothesis
- 8.3.3. Results and Interpretation
  - 8.3.3.1. Product Price Evaluation Matrix: Information on Type of Test Format
  - 8.3.3.2. Product Price Evaluation Matrix: Information on Type of Analyte Procurement Method Used
  - 8.3.3.3. Product Price Evaluation Matrix: Information on Type of Biofluid Analyzed
  - 8.3.3.4. Product Price Evaluation Matrix: Information on Number of Regulatory Approvals Received
  - 8.3.3.5. Product Price Evaluation Matrix: Information on Target Patient Population
  - 8.3.3.6. Product Price Evaluation Matrix: Information on Availability of Data Management Tools
  - 8.3.3.7. Product Price Evaluation Matrix: Information on Target Analyte Detected

9. COMPANY COMPARABLE ANALYSIS

9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Operating Statistics for Comparable Companies
- 9.3.1. Operating Statistics: Abbott Laboratories
- 9.3.2. Operating Statistics: Roche
- 9.3.3. Operating Statistics: Johnson & Johnson
- 9.3.4. Operating Statistics: Median, 25th And 75th Percentile Multiple
9.4. Valuation Statistics for Comparable Companies
- 9.4.1. Valuation Statistics: Abbott Laboratories
- 9.4.2. Valuation Statistics: Roche
- 9.4.3. Valuation Statistics: Johnson & Johnson
- 9.4.4. Valuation Statistics: Median, 25th And 75th Percentile Multiple
9.5. Valuation Summary for Abbott Laboratories
- 9.5.1. Valuation Summary: Implied Share Price from Discount Cash Flow
- 9.5.2. Football Field Analysis: Abbott Laboratories
9.6. Valuation Summary for Roche
- 9.6.1. Valuation Summary: Implied Share Price from Discount Cash Flow
- 9.6.2. Football Field Analysis: Roche
9.7. Valuation Summary for Johnson & Johnson
- 9.7.1. Valuation Summary: Implied Share Price from Discount Cash Flow
- 9.7.2. Football Field Analysis: Johnson & Johnson

10. DEMAND ANALYSIS

10.1. Chapter Overview
10.2. Scope and Methodology
10.3. Global Demand for At-home Self-testing Kits
10.4. Demand for At-home Self-testing Kits: Analysis by Geography
10.5. Demand for At-home Self-testing Kits: Analysis by Therapeutic Area
- 10.5.1. Demand for At-home Self-testing Fertility and Reproductive Health Kits
  - 10.5.1.1. Demand for At-home Self-testing Pregnancy Test Kits
    - 10.5.1.1.1. Demand for At-home Self-testing Pregnancy Test Kits in North America
      - 10.5.1.1.1.1. Demand for At-home Self-testing Pregnancy Test Kits in the US
      - 10.5.1.1.1.2. Demand for At-home Self-testing Pregnancy Test Kits in Canada
      - 10.5.1.1.1.3. Demand for At-home Self-testing Pregnancy Test Kits in Rest of North America
    - 10.5.1.1.2. Demand for At-home Self-testing Pregnancy Test Kits in Europe
      - 10.5.1.1.2.1. Demand for At-home Self-testing Pregnancy Test Kits in the UK
      - 10.5.1.1.2.2. Demand for At-home Self-testing Pregnancy Test Kits in Germany
      - 10.5.1.1.2.3. Demand for At-home Self-testing Pregnancy Test Kits in Spain
      - 10.5.1.1.2.4. Demand for At-home Self-testing Pregnancy Test Kits in Italy
      - 10.5.1.1.2.5. Demand for At-home Self-testing Pregnancy Test Kits in France
      - 10.5.1.1.2.6. Demand for At-home Self-testing Pregnancy Test Kits in Rest of Europe
    - 10.5.1.1.3. Demand for At-home Self-testing Pregnancy Test Kits in Asia-Pacific
      - 10.5.1.1.3.1. Demand for At-home Self-testing Pregnancy Test Kits in India
      - 10.5.1.1.3.2. Demand for At-home Self-testing Pregnancy Test Kits in China
      - 10.5.1.1.3.3. Demand for At-home Self-testing Pregnancy Test Kits in Japan
      - 10.5.1.1.3.4. Demand for At-home Self-testing Pregnancy Test Kits in South Korea
      - 10.5.1.1.3.5. Demand for At-home Self-testing Pregnancy Test Kits in Indonesia
      - 10.5.1.1.3.6. Demand for At-home Self-testing Pregnancy Test Kits in Rest of Asia-Pacific
    - 10.5.1.1.4. Demand for At-home Self-testing Pregnancy Test Kits in Africa
      - 10.5.1.1.4.1. Demand for At-home Self-testing Pregnancy Test Kits in Nigeria
      - 10.5.1.1.4.2. Demand for At-home Self-testing Pregnancy Test Kits in Ethiopia
      - 10.5.1.1.4.3. Demand for At-home Self-testing Pregnancy Test Kits in Egypt
      - 10.5.1.1.4.4. Demand for At-home Self-testing Pregnancy Test Kits in Rest of Africa
    - 10.5.1.1.5. Demand for At-home Self-testing Pregnancy Test Kits in South America
      - 10.5.1.1.5.1. Demand for At-home Self-testing Pregnancy Test Kits in Argentina
      - 10.5.1.1.5.2. Demand for At-home Self-testing Pregnancy Test Kits in Brazil
      - 10.5.1.1.5.3. Demand for At-home Self-testing Pregnancy Test Kits in Rest of South America
  - 10.5.1.2. Demand for At-home Self-testing Ovulation Test Kits
    - 10.5.1.2.1. Demand for At-home Self-testing Ovulation Test Kits in North America
      - 10.5.1.2.1.1. Demand for At-home Self-testing Ovulation Test Kits in the US
      - 10.5.1.2.1.2. Demand for At-home Self-testing Ovulation Test Kits in Canada
      - 10.5.1.2.1.3. Demand for At-home Self-testing Ovulation Test Kits in Rest of North America
    - 10.5.1.2.2. Demand for At-home Self-testing Ovulation Test Kits in Europe
      - 10.5.1.2.2.1. Demand for At-home Self-testing Ovulation Test Kits in the UK
      - 10.5.1.2.2.2. Demand for At-home Self-testing Ovulation Test Kits in Germany
      - 10.5.1.2.2.3. Demand for At-home Self-testing Ovulation Test Kits in Spain
      - 10.5.1.2.2.4. Demand for At-home Self-testing Ovulation Test Kits in Italy
      - 10.5.1.2.2.5. Demand for At-home Self-testing Ovulation Test Kits in France
      - 10.5.1.2.2.6. Demand for At-home Self-testing Ovulation Test Kits in Rest of Europe
    - 10.5.1.2.3. Demand for At-home Self-testing Ovulation Test Kits in Asia-Pacific
      - 10.5.1.2.3.1. Demand for At-home Self-testing Ovulation Test Kits in India
      - 10.5.1.2.3.2. Demand for At-home Self-testing Ovulation Test Kits in China
      - 10.5.1.2.3.3. Demand for At-home Self-testing Ovulation Test Kits in Japan
      - 10.5.1.2.3.4. Demand for At-home Self-testing Ovulation Test Kits in South Korea
      - 10.5.1.2.3.5. Demand for At-home Self-testing Ovulation Test Kits in Indonesia
      - 10.5.1.2.3.6. Demand for At-home Self-testing Ovulation Test Kits in Rest of Asia-Pacific
    - 10.5.1.2.4. Demand for At-home Self-testing Ovulation Test Kits in Africa
      - 10.5.1.2.4.1. Demand for At-home Self-testing Ovulation Test Kits in Nigeria
      - 10.5.1.2.4.2. Demand for At-home Self-testing Ovulation Test Kits in Ethiopia
      - 10.5.1.2.4.3. Demand for At-home Self-testing Ovulation Test Kits in Egypt
      - 10.5.1.2.4.4. Demand for At-home Self-testing Ovulation Test Kits in Rest of Africa
    - 10.5.1.2.5. Demand for At-home Self-testing Ovulation Test Kits in South America
      - 10.5.1.2.5.1. Demand for At-home Self-testing Ovulation Test Kits in Argentina
      - 10.5.1.2.5.2. Demand for At-home Self-testing Ovulation Test Kits in Brazil
      - 10.5.1.2.5.3. Demand for At-home Self-testing Ovulation Test Kits in Rest of South America
- 10.5.2. Demand for At-home Self-testing Infectious Diseases Kits
  - 10.5.2.1. Demand for At-home Self-testing HIV Test Kits
    - 10.5.2.1.1. Demand for At-home Self-testing HIV Test Kits in North America
      - 10.5.2.1.1.1. Demand for At-home Self-testing HIV Test Kits in the US
      - 10.5.2.1.1.2. Demand for At-home Self-testing HIV Test Kits in Canada
      - 10.5.2.1.1.3. Demand for At-home Self-testing HIV Test Kits in Rest of North America
    - 10.5.2.1.2. Demand for At-home Self-testing HIV Test Kits in Europe
      - 10.5.2.1.2.1. Demand for At-home Self-testing HIV Test Kits in the UK
      - 10.5.2.1.2.2. Demand for At-home Self-testing HIV Test Kits in Germany
      - 10.5.2.1.2.3. Demand for At-home Self-testing HIV Test Kits in Spain
      - 10.5.2.1.2.4. Demand for At-home Self-testing HIV Test Kits in Italy
      - 10.5.2.1.2.5. Demand for At-home Self-testing HIV Test Kits in France
      - 10.5.2.1.2.6. Demand for At-home Self-testing HIV Test Kits in Rest of Europe
    - 10.5.2.1.3. Demand for At-home Self-testing HIV Test Kits in Asia-Pacific
      - 10.5.2.1.3.1. Demand for At-home Self-testing HIV Test Kits in India
      - 10.5.2.1.3.2. Demand for At-home Self-testing HIV Test Kits in China
      - 10.5.2.1.3.3. Demand for At-home Self-testing HIV Test Kits in Japan
      - 10.5.2.1.3.4. Demand for At-home Self-testing HIV Test Kits in South Korea
      - 10.5.2.1.3.5. Demand for At-home Self-testing HIV Test Kits in Indonesia
      - 10.5.2.1.3.6. Demand for At-home Self-testing HIV Test Kits in Rest of Asia-Pacific
    - 10.5.2.1.4. Demand for At-home Self-testing HIV Test Kits in Africa
      - 10.5.2.1.4.1. Demand for At-home Self-testing HIV Test Kits in Nigeria
      - 10.5.2.1.4.2. Demand for At-home Self-testing HIV Test Kits in Ethiopia
      - 10.5.2.1.4.3. Demand for At-home Self-testing HIV Test Kits in Egypt
      - 10.5.2.1.4.4. Demand for At-home Self-testing HIV Test Kits in Rest of Africa
    - 10.5.2.1.5. Demand for At-home Self-testing HIV Test Kits in South America
      - 10.5.2.1.5.1. Demand for At-home Self-testing HIV Test Kits in Argentina
      - 10.5.2.1.5.2. Demand for At-home Self-testing HIV Test Kits in Brazil
      - 10.5.2.1.5.3. Demand for At-home Self-testing HIV Test Kits in Rest of South America
- 10.5.3. Demand for At-home Self-testing Metabolic Disorders Kits
  - 10.5.3.1. Demand for At-home Self-testing Diabetes Test Kits
    - 10.5.3.1.1. Demand for At-home Self-testing Diabetes Test Kits in North America
      - 10.5.3.1.1.1. Demand for At-home Self-testing Diabetes Test Kits in the US
      - 10.5.3.1.1.2. Demand for At-home Self-testing Diabetes Test Kits in Canada
      - 10.5.3.1.1.3. Demand for At-home Self-testing Diabetes Test Kits in Rest of North America
    - 10.5.3.1.2. Demand for At-home Self-testing Diabetes Test Kits in Europe
      - 10.5.3.1.2.1. Demand for At-home Self-testing Diabetes Test Kits in the UK
      - 10.5.3.1.2.2. Demand for At-home Self-testing Diabetes Test Kits in Germany
      - 10.5.3.1.2.3. Demand for At-home Self-testing Diabetes Test Kits in Spain
      - 10.5.3.1.2.4. Demand for At-home Self-testing Diabetes Test Kits in Italy
      - 10.5.3.1.2.5. Demand for At-home Self-testing Diabetes Test Kits in France
      - 10.5.3.1.2.6. Demand for At-home Self-testing Diabetes Test Kits in Rest of Europe
    - 10.5.3.1.3. Demand for At-home Self-testing Diabetes Test Kits in Asia-Pacific
      - 10.5.3.1.3.1. Demand for At-home Self-testing Diabetes Test Kits in India
      - 10.5.3.1.3.2. Demand for At-home Self-testing Diabetes Test Kits in China
      - 10.5.3.1.3.3. Demand for At-home Self-testing Diabetes Test Kits in Japan
      - 10.5.3.1.3.4. Demand for At-home Self-testing Diabetes Test Kits in South Korea
      - 10.5.3.1.3.5. Demand for At-home Self-testing Diabetes Test Kits in Indonesia
      - 10.5.3.1.3.6. Demand for At-home Self-testing Diabetes Test Kits in Rest of Asia-Pacific
    - 10.5.3.1.4. Demand for At-home Self-testing Diabetes Test Kits in Africa
      - 10.5.3.1.4.1. Demand for At-home Self-testing Diabetes Test Kits in Nigeria
      - 10.5.3.1.4.2. Demand for At-home Self-testing Diabetes Test Kits in Ethiopia
      - 10.5.3.1.4.3. Demand for At-home Self-testing Diabetes Test Kits in Egypt
      - 10.5.3.1.4.4. Demand for At-home Self-testing Diabetes Test Kits in Rest of Africa
    - 10.5.3.1.5. Demand for At-home Self-testing Diabetes Test Kits in South America
      - 10.5.3.1.5.1. Demand for At-home Self-testing Diabetes Test Kits in Argentina
      - 10.5.3.1.5.2. Demand for At-home Self-testing Diabetes Test Kits in Brazil
      - 10.5.3.1.5.3. Demand for At-home Self-testing Diabetes Test Kits in Rest of South America
- 10.5.4. Demand for At-home Self-testing Oncological Disorders Kits
  - 10.5.4.1. Demand for At-home Self-testing Colon Cancer Test Kits
    - 10.5.4.1.1. Demand for At-home Self-testing Colon Cancer Test Kits in North America
      - 10.5.4.1.1.1. Demand for At-home Self-testing Colon Cancer Test Kits in the US
      - 10.5.4.1.1.2. Demand for At-home Self-testing Colon Cancer Test Kits in Canada
      - 10.5.4.1.1.3. Demand for At-home Self-testing Colon Cancer Test Kits in Rest of North America
    - 10.5.4.1.2. Demand for At-home Self-testing Colon Cancer Test Kits in Europe
      - 10.5.4.1.2.1. Demand for At-home Self-testing Colon Cancer Test Kits in the UK
      - 10.5.4.1.2.2. Demand for At-home Self-testing Colon Cancer Test Kits in Germany
      - 10.5.4.1.2.3. Demand for At-home Self-testing Colon Cancer Test Kits in Spain
      - 10.5.4.1.2.4. Demand for At-home Self-testing Colon Cancer Test Kits in Italy
      - 10.5.4.1.2.5. Demand for At-home Self-testing Colon Cancer Test Kits in France
      - 10.5.4.1.2.6. Demand for At-home Self-testing Colon Cancer Test Kits in Rest of Europe
    - 10.5.4.1.3. Demand for At-home Self-testing Colon Cancer Test Kits in Asia-Pacific
      - 10.5.4.1.3.1. Demand for At-home Self-testing Colon Cancer Test Kits in India
      - 10.5.4.1.3.2. Demand for At-home Self-testing Colon Cancer Test Kits in China
      - 10.5.4.1.3.3. Demand for At-home Self-testing Colon Cancer Test Kits in Japan
      - 10.5.4.1.3.4. Demand for At-home Self-testing Colon Cancer Test Kits in South Korea
      - 10.5.4.1.3.5. Demand for At-home Self-testing Colon Cancer Test Kits in Indonesia
      - 10.5.4.1.3.6. Demand for At-home Self-testing Colon Cancer Test Kits in Rest of Asia-Pacific
    - 10.5.4.1.4. Demand for At-home Self-testing Colon Cancer Test Kits in Africa
      - 10.5.4.1.4.1. Demand for At-home Self-testing Colon Cancer Test Kits in Nigeria
      - 10.5.4.1.4.2. Demand for At-home Self-testing Colon Cancer Test Kits in Ethiopia
      - 10.5.4.1.4.3. Demand for At-home Self-testing Colon Cancer Test Kits in Egypt
      - 10.5.4.1.4.4. Demand for At-home Self-testing Colon Cancer Test Kits in Rest of Africa
    - 10.5.4.1.5. Demand for At-home Self-testing Colon Cancer Test Kits in South America
      - 10.5.4.1.5.1. Demand for At-home Self-testing Colon Cancer Test Kits in Argentina
      - 10.5.4.1.5.2. Demand for At-home Self-testing Colon Cancer Test Kits in Brazil
      - 10.5.4.1.5.3. Demand for At-home Self-testing Colon Cancer Test Kits in Rest of South America
10.6. Concluding Remarks

11. MARKET FORECAST AND OPPUTUNITY ANALYSIS

11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Global At-home Self-testing Kits Market, 2022-2035
11.4. At-home Self-testing Kits Market: Analysis by Geography, 2022-2035
11.5. At-home Self-testing Kits Market: Analysis by Therapeutic Area, 2022-2035
- 11.5.1. At-home Self-testing Kits Market for Fertility and Reproductive Health, 2022-2035
  - 11.5.1.1. At-home Self-testing Kits Market for Pregnancy Detection, 2022-2035
    - 11.5.1.1.1. At-home Self-testing Kits Market for Pregnancy Detection in North America, 2022-2035
      - 11.5.1.1.1.1. At-home Self-testing Kits Market for Pregnancy Detection in the US, 2022-2035
      - 11.5.1.1.1.2. At-home Self-testing Kits Market for Pregnancy Detection in Canada, 2022-2035
      - 11.5.1.1.1.3. At-home Self-testing Kits Market for Pregnancy Detection in Rest of North America, 2022-2035
    - 11.5.1.1.2. At-home Self-testing Kits Market for Pregnancy Detection in Europe, 2022-2035
      - 11.5.1.1.2.1. At-home Self-testing Kits Market for Pregnancy Detection in the UK, 2022-2035
      - 11.5.1.1.2.2. At-home Self-testing Kits Market for Pregnancy Detection in Germany, 2022-2035
      - 11.5.1.1.2.3. At-home Self-testing Kits Market for Pregnancy Detection in Spain, 2022-2035
      - 11.5.1.1.2.4. At-home Self-testing Kits Market for Pregnancy Detection in Italy, 2022-2035
      - 11.5.1.1.2.5. At-home Self-testing Kits Market for Pregnancy Detection in France, 2022-2035
      - 11.5.1.1.2.6. At-home Self-testing Kits Market for Pregnancy Detection in Rest of Europe, 2022-2035
    - 11.5.1.1.3. At-home Self-testing Kits Market for Pregnancy Detection in Asia-Pacific, 2022-2035
      - 11.5.1.1.3.1. At-home Self-testing Kits Market for Pregnancy Detection in India, 2022-2035
      - 11.5.1.1.3.2. At-home Self-testing Kits Market for Pregnancy Detection in China, 2022-2035
      - 11.5.1.1.3.3. At-home Self-testing Kits Market for Pregnancy Detection in Japan, 2022-2035
      - 11.5.1.1.3.4. At-home Self-testing Kits Market for Pregnancy Detection in South Korea, 2022-2035
      - 11.5.1.1.3.5. At-home Self-testing Kits Market for Pregnancy Detection in Indonesia, 2022-2035
      - 11.5.1.1.3.6. At-home Self-testing Kits Market for Pregnancy Detection in Rest of Asia-Pacific, 2022-2035
    - 11.5.1.1.4. At-home Self-testing Kits Market for Pregnancy Detection in Africa, 2022-2035
      - 11.5.1.1.4.1. At-home Self-testing Kits Market for Pregnancy Detection in Nigeria, 2022-2035
      - 11.5.1.1.4.2. At-home Self-testing Kits Market for Pregnancy Detection in Ethiopia, 2022-2035
      - 11.5.1.1.4.3. At-home Self-testing Kits Market for Pregnancy Detection in Egypt, 2022-2035
      - 11.5.1.1.4.4. At-home Self-testing Kits Market for Pregnancy Detection in Rest of Africa, 2022-2035
    - 11.5.1.1.5. At-home Self-testing Kits Market for Pregnancy Detection in South America, 2022-2035
      - 11.5.1.1.5.1. At-home Self-testing Kits Market for Pregnancy Detection in Argentina, 2022-2035
      - 11.5.1.1.5.2. At-home Self-testing Kits Market for Pregnancy Detection in Brazil, 2022-2035
      - 11.5.1.1.5.3. At-home Self-testing Kits Market for Pregnancy Detection in Rest of South America, 2022-2035
  - 11.5.1.2. At-home Self-testing Kits Market for Ovulation Monitoring, 2022-2035
    - 11.5.1.2.1. At-home Self-testing Kits Market for Ovulation Monitoring in North America, 2022-2035
      - 11.5.1.2.1.1. At-home Self-testing Kits Market for Ovulation Monitoring in the US, 2022-2035
      - 11.5.1.2.1.2. At-home Self-testing Kits Market for Ovulation Monitoring in Canada, 2022-2035
      - 11.5.1.2.1.3. At-home Self-testing Kits Market for Ovulation Monitoring in Rest of North America, 2022-2035
    - 11.5.1.2.2. At-home Self-testing Kits Market for Ovulation Monitoring in Europe, 2022-2035
      - 11.5.1.2.2.1. At-home Self-testing Kits Market for Ovulation Monitoring in the UK, 2022-2035
      - 11.5.1.2.2.2. At-home Self-testing Kits Market for Ovulation Monitoring in Germany, 2022-2035
      - 11.5.1.2.2.3. At-home Self-testing Kits Market for Ovulation Monitoring in Spain, 2022-2035
      - 11.5.1.2.2.4. At-home Self-testing Kits Market for Ovulation Monitoring in Italy, 2022-2035
      - 11.5.1.2.2.5. At-home Self-testing Kits Market for Ovulation Monitoring in France, 2022-2035
      - 11.5.1.2.2.6. At-home Self-testing Kits Market for Ovulation Monitoring in Rest of Europe, 2022-2035
    - 11.5.1.2.3. At-home Self-testing Kits Market for Ovulation Monitoring in Asia-Pacific, 2022-2035
      - 11.5.1.2.3.1. At-home Self-testing Kits Market for Ovulation Monitoring in India, 2022-2035
      - 11.5.1.2.3.2. At-home Self-testing Kits Market for Ovulation Monitoring in China, 2022-2035
      - 11.5.1.2.3.3. At-home Self-testing Kits Market for Ovulation Monitoring in Japan, 2022-2035
      - 11.5.1.2.3.4. At-home Self-testing Kits Market for Ovulation Monitoring in South Korea, 2022-2035
      - 11.5.1.2.3.5. At-home Self-testing Kits Market for Ovulation Monitoring in Indonesia, 2022-2035
      - 11.5.1.2.3.6. At-home Self-testing Kits Market for Ovulation Monitoring in Rest of Asia-Pacific, 2022-2035
    - 11.5.1.2.4. At-home Self-testing Kits Market for Ovulation Monitoring in Africa, 2022-2035
      - 11.5.1.2.4.1. At-home Self-testing Kits Market for Ovulation Monitoring in Nigeria, 2022-2035
      - 11.5.1.2.4.2. At-home Self-testing Kits Market for Ovulation Monitoring in Ethiopia, 2022-2035
      - 11.5.1.2.4.3. At-home Self-testing Kits Market for Ovulation Monitoring in Egypt, 2022-2035
      - 11.5.1.2.4.4. At-home Self-testing Kits Market for Ovulation Monitoring in Rest of Africa, 2022-2035
    - 11.5.1.2.5. At-home Self-testing Kits Market for Ovulation Monitoring in South America, 2022-2035
      - 11.5.1.2.5.1. At-home Self-testing Kits Market for Ovulation Monitoring in Argentina, 2022-2035
      - 11.5.1.2.5.2. At-home Self-testing Kits Market for Ovulation Monitoring in Brazil, 2022-2035
      - 11.5.1.2.5.3. At-home Self-testing Kits Market for Ovulation Monitoring in Rest of South America, 2022-2035
- 11.5.2. At-home Self-testing Kits Market for Infectious Diseases, 2022-2035
  - 11.5.2.1. At-home Self-testing Kits Market for HIV Detection, 2022-2035
    - 11.5.2.1.1. At-home Self-testing Kits Market for HIV Detection in North America, 2022-2035
      - 11.5.2.1.1.1. At-home Self-testing Kits Market for HIV Detection in the US, 2022-2035
      - 11.5.2.1.1.2. At-home Self-testing Kits Market for HIV Detection in Canada, 2022-2035
      - 11.5.2.1.1.3. At-home Self-testing Kits Market for HIV Detection in Rest of North America, 2022-2035
    - 11.5.2.1.2. At-home Self-testing Kits Market for HIV Detection in Europe, 2022-2035
      - 11.5.2.1.2.1. At-home Self-testing Kits Market for HIV Detection in the UK, 2022-2035
      - 11.5.2.1.2.2. At-home Self-testing Kits Market for HIV Detection in Germany, 2022-2035
      - 11.5.2.1.2.3. At-home Self-testing Kits Market for HIV Detection in Spain, 2022-2035
      - 11.5.2.1.2.4. At-home Self-testing Kits Market for HIV Detection in Italy, 2022-2035
      - 11.5.2.1.2.5. At-home Self-testing Kits Market for HIV Detection in France, 2022-2035
      - 11.5.2.1.2.6. At-home Self-testing Kits Market for HIV Detection in Rest of Europe, 2022-2035
    - 11.5.2.1.3. At-home Self-testing Kits Market for HIV Detection in Asia-Pacific, 2022-2035
      - 11.5.2.1.3.1. At-home Self-testing Kits Market for HIV Detection in India, 2022-2035
      - 11.5.2.1.3.2. At-home Self-testing Kits Market for HIV Detection in China, 2022-2035
      - 11.5.2.1.3.3. At-home Self-testing Kits Market for HIV Detection in Japan, 2022-2035
      - 11.5.2.1.3.4. At-home Self-testing Kits Market for HIV Detection in South Korea, 2022-2035
      - 11.5.2.1.3.5. At-home Self-testing Kits Market for HIV Detection in Indonesia, 2022-2035
      - 11.5.2.1.3.6. At-home Self-testing Kits Market for HIV Detection in Rest of Asia-Pacific, 2022-2035
    - 11.5.2.1.4. At-home Self-testing Kits Market for HIV Detection in Africa, 2022-2035
      - 11.5.2.1.4.1. At-home Self-testing Kits Market for HIV Detection in Nigeria, 2022-2035
      - 11.5.2.1.4.2. At-home Self-testing Kits Market for HIV Detection in Ethiopia, 2022-2035
      - 11.5.2.1.4.3. At-home Self-testing Kits Market for HIV Detection in Egypt, 2022-2035
      - 11.5.2.1.4.4. At-home Self-testing Kits Market for HIV Detection in Rest of Africa, 2022-2035
    - 11.5.2.1.5. At-home Self-testing Kits Market for HIV Detection in South America, 2022-2035
      - 11.5.2.1.5.1. At-home Self-testing Kits Market for HIV Detection in Argentina, 2022-2035
      - 11.5.2.1.5.2. At-home Self-testing Kits Market for HIV Detection in Brazil, 2022-2035
      - 11.5.2.1.5.3. At-home Self-testing Kits Market for HIV Detection in Rest of South America, 2022-2035
- 11.5.3. At-home Self-testing Kits Market for Metabolic Disorders, 2022-2035
  - 11.5.3.1. At-home Self-testing Kits Market for Diabetes Monitoring, 2022-2035
    - 11.5.3.1.1. At-home Self-testing Kits Market for Diabetes Monitoring in North America, 2022-2035
      - 11.5.3.1.1.1. At-home Self-testing Kits Market for Diabetes Monitoring in the US, 2022-2035
      - 11.5.3.1.1.2. At-home Self-testing Kits Market for Diabetes Monitoring in Canada, 2022-2035
      - 11.5.3.1.1.3. At-home Self-testing Kits Market for Diabetes Monitoring in Rest of North America, 2022-2035
    - 11.5.3.1.2. At-home Self-testing Kits Market for Diabetes Monitoring in Europe, 2022-2035
      - 11.5.3.1.2.1. At-home Self-testing Kits Market for Diabetes Monitoring in the UK, 2022-2035
      - 11.5.3.1.2.2. At-home Self-testing Kits Market for Diabetes Monitoring in Germany, 2022-2035
      - 11.5.3.1.2.3. At-home Self-testing Kits Market for Diabetes Monitoring in Spain, 2022-2035
      - 11.5.3.1.2.4. At-home Self-testing Kits Market for Diabetes Monitoring in Italy, 2022-2035
      - 11.5.3.1.2.5. At-home Self-testing Kits Market for Diabetes Monitoring in France, 2022-2035
      - 11.5.3.1.2.6. At-home Self-testing Kits Market for Diabetes Monitoring in Rest of Europe, 2022-2035
    - 11.5.3.1.3. At-home Self-testing Kits Market for Diabetes Monitoring in Asia-Pacific, 2022-2035
      - 11.5.3.1.3.1. At-home Self-testing Kits Market for Diabetes Monitoring in India, 2022-2035
      - 11.5.3.1.3.2. At-home Self-testing Kits Market for Diabetes Monitoring in China, 2022-2035
      - 11.5.3.1.3.3. At-home Self-testing Kits Market for Diabetes Monitoring in Japan, 2022-2035
      - 11.5.3.1.3.4. At-home Self-testing Kits Market for Diabetes Monitoring in South Korea, 2022- 2035
      - 11.5.3.1.3.5. At-home Self-testing Kits Market for Diabetes Monitoring in Indonesia, 2022-2035
      - 11.5.3.1.3.6. At-home Self-testing Kits Market for Diabetes Monitoring in Rest of Asia-Pacific, 2022-2035
    - 11.5.3.1.4. At-home Self-testing Kits Market for Diabetes Monitoring in Africa, 2022-2035
      - 11.5.3.1.4.1. At-home Self-testing Kits Market for Diabetes Monitoring in Nigeria, 2022-2035
      - 11.5.3.1.4.2. At-home Self-testing Kits Market for Diabetes Monitoring in Ethiopia, 2022-2035
      - 11.5.3.1.4.3. At-home Self-testing Kits Market for Diabetes Monitoring in Egypt, 2022-2035
      - 11.5.3.1.4.4. At-home Self-testing Kits Market for Diabetes Monitoring in Rest of Africa, 2022-2035
    - 11.5.3.1.5. At-home Self-testing Kits Market for Diabetes Monitoring in South America, 2022-2035
      - 11.5.3.1.5.1. At-home Self-testing Kits Market for Diabetes Monitoring in Argentina, 2022-2035
      - 11.5.3.1.5.2. At-home Self-testing Kits Market for Diabetes Monitoring in Brazil, 2022-2035
      - 11.5.3.1.5.3. At-home Self-testing Kits Market for Diabetes Monitoring in Rest of South America, 2022-2035
- 11.5.4. At-home Self-testing Kits Market for Oncological Disorders, 2022-2035
  - 11.5.4.1. At-home Self-testing Kits Market for Colon Cancer Detection, 2022-2035
    - 11.5.4.1.1. At-home Self-testing Kits Market for Colon Cancer Detection in North America, 2022-2035
      - 11.5.4.1.1.1. At-home Self-testing Kits Market for Colon Cancer Detection in the US, 2022-2035
      - 11.5.4.1.1.2. At-home Self-testing Kits Market for Colon Cancer Detection in Canada, 2022-2035
      - 11.5.4.1.1.3. At-home Self-testing Kits Market for Colon Cancer Detection in Rest of North America, 2022-2035
    - 11.5.4.1.2. At-home Self-testing Kits Market for Colon Cancer Detection in Europe, 2022-2035
      - 11.5.4.1.2.1. At-home Self-testing Kits Market for Colon Cancer Detection in the UK, 2022-2035
      - 11.5.4.1.2.2. At-home Self-testing Kits Market for Colon Cancer Detection in Germany, 2022-2035
      - 11.5.4.1.2.3. At-home Self-testing Kits Market for Colon Cancer Detection in Spain, 2022-2035
      - 11.5.4.1.2.4. At-home Self-testing Kits Market for Colon Cancer Detection in Italy, 2022-2035
      - 11.5.4.1.2.5. At-home Self-testing Kits Market for Colon Cancer Detection in France, 2022-2035
      - 11.5.4.1.2.6. At-home Self-testing Kits Market for Colon Cancer Detection in Rest of Europe, 2022-2035
    - 11.5.4.1.3. At-home Self-testing Kits Market for Colon Cancer Detection in Asia-Pacific, 2022-2035
      - 11.5.4.1.3.1. At-home Self-testing Kits Market for Colon Cancer Detection in India, 2022-2035
      - 11.5.4.1.3.2. At-home Self-testing Kits Market for Colon Cancer Detection in China, 2022-2035
      - 11.5.4.1.3.3. At-home Self-testing Kits Market for Colon Cancer Detection in Japan, 2022-2035
      - 11.5.4.1.3.4. At-home Self-testing Kits Market for Colon Cancer Detection in South Korea, 2022-2035
      - 11.5.4.1.3.5. At-home Self-testing Kits Market for Colon Cancer Detection in Indonesia, 2022-2035
      - 11.5.4.1.3.6. At-home Self-testing Kits Market for Colon Cancer Detection in Rest of Asia-Pacific, 2022-2035
    - 11.5.4.1.4. At-home Self-testing Kits Market for Colon Cancer Detection in Africa, 2022-2035
      - 11.5.4.1.4.1. At-home Self-testing Kits Market for Colon Cancer Detection in Nigeria, 2022-2035
      - 11.5.4.1.4.2. At-home Self-testing Kits Market for Colon Cancer Detection in Ethiopia, 2022-2035
      - 11.5.4.1.4.3. At-home Self-testing Kits Market for Colon Cancer Detection in Egypt, 2022-2035
      - 11.5.4.1.4.4. At-home Self-testing Kits Market for Colon Cancer Detection in Rest of Africa, 2022-2035
    - 11.5.4.1.5. At-home Self-testing Kits Market for Colon Cancer Detection in South America, 2022-2035
      - 11.5.4.1.5.1. At-home Self-testing Kits Market for Colon Cancer Detection in Argentina, 2022-2035
      - 11.5.4.1.5.2. At-home Self-testing Kits Market for Colon Cancer Detection in Brazil, 2022-2035
      - 11.5.4.1.5.3. At-home Self-testing Kits Market for Colon Cancer Detection in Rest of South America
11.6. At-home Self-testing Kits Market: Analysis by Type of Test Format, 2022-2035
- 11.6.1. At-home Self-testing Kits Market for Stick based Tests, 2022-2035
- 11.6.2. At-home Self-testing Kits Market for Strip based Tests, 2022-2035
- 11.6.3. At-home Self-testing Kits Market for Cassette based Tests, 2022-2035
11.7. At-home Self-testing Kits Market: Analysis by Type of Biofluid Analyzed, 2022-2035
- 11.7.1. At-home Self-testing Kits Market for Urine based Tests, 2022-2035
- 11.7.2. At-home Self-testing Kits Market for Blood based Tests, 2022-2035

12. ATTRACTIVENESS COMPETETIVENESS MATRIX

12.1. Chapter Overview
12.2. AC Matrix: Overview
- 12.2.1. Strong Business Segments
- 12.2.2. Average Business Segments
- 12.2.3. Weak Business Segments
12.3. Analytical Methodology
12.4. AC Matrix: At-home Self-testing Kits in North America
12.5. AC Matrix: At-home Self-testing Kits in Europe
12.6. AC Matrix: At-home Self-testing Kits in Asia-Pacific

13. CONCLUDING REMARKS

14. INTERVIEW TRANSCRIPTS

14.1. Chapter Overview
14.2. Apex Biotechnology
- 14.2.1. Company Snapshot
- 14.2.2. Interview Transcript: Ben Shen (Vice President, Sales and Marketing)
14.3. Mankind Pharma
- 14.3.1. Company Snapshot
- 14.3.2. Interview Transcript: Joy Chatterjee (Associate Vice President)

15. APPENDIX I: TABULATED DATA

16. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS